Review Article
Lm-LLO-Based Immunotherapies and HPV-Associated Disease
Table 1
Modification of Lm-LLO-based immunotherapy for HPV-associated cervical cancer.
| Vaccine name | Design | Strain modification | Antigen | Ref. |
| ADXS11-001 (Lm-LLO-E7) | Plasmid | prfA − | E7, HPV-16 | [7] | Lm-PEST-E7 | Plasmid | prfA − | E7, HPV-16 | [8] | Lm-ActA-E7 | Plasmid | prfA − | E7, HPV-16 | [8] | Lm-dd-TV | Plasmid | dal −dat − | E7, HPV-16 | [9] |
|
|